Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 10, 2024 06:00 ET | Source: Beam Global

Beam Global To Enter Ethiopian Market: Appoints Agent Partner for Africa’s First Off-Grid Renewably Energized EV Charging and Energy Resiliency Infrastructure

Beam Global To Enter Ethiopian Market: Appoints Agent Partner for Africa’s First Off-Grid Renewably Energized EV Charging and Energy Resiliency Infrastruct
October 10, 2024 05:41 ET | Source: Research and Markets

RTD (Ready to Drink) Cocktail Analysis Report 2023-2024 & 2029: Online Distribution Channel Poised for Fastest Growth, Brands in North America and Europe Focus on Craftsmanship

Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Global RTD Cocktail Market: Analysis By Type, By Flavor Type (Flavored and Unflavored), By Packaging (Bottles, Cans, and Others), By Distribution...
October 10, 2024 04:27 ET | Source: Research and Markets

Geriatric Medicine Industry Assessment 2024-2030, Featuring Profiles of Key Players - Roche, Novartis, AbbVie, Johnson & Johnson Services, Merck and Co & More

Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Geriatric Medicine Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The global...
October 10, 2024 04:00 ET | Source: Cyber A.I. Group, Inc.

Cyber A.I. Group and A1 Advisory Announce Strategic Partnership

CyberAI Group partners with A1 Advisory to secure capital and global alliances, accelerating growth in cybersecurity and AI through strategic acquisitions.
October 10, 2024 03:00 ET | Source: MitoRx Therapeutics

MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity

OXFORD, United Kingdom, Oct. 10, 2024 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted sulfide-donor therapeutics (mtH2SD)...
October 10, 2024 02:28 ET | Source: AB Science

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS OF THE PERIOD Clinical development Masitinib platform: Ongoing...
October 10, 2024 02:00 ET | Source: Cornish Metals Inc.

Cornish Metals Appoints Endeavour Financial as Financial Adviser to Arrange Project Financing for South Crofty Tin Project

Cornish Metals announces it has appointed Endeavour Financial as financial adviser to secure project financing for the construction of South Crofty.
October 10, 2024 02:00 ET | Source: Avacta Group

Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium

10 OctoberAvacta Group plc(“Avacta” or “the Group” or “the Company”)Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium...
October 10, 2024 02:00 ET | Source: Vast Resources PLC

Corporate Update

Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining 10 October 2024 Vast Resources plc(‘Vast’ or the ‘Company’) Corporate Update Vast Resources plc, the AIM-listed mining...
October 10, 2024 01:00 ET | Source: Pharming Group N.V.

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation

Proof of concept clinical trial will evaluate leniolisib in PIDs with immune dysregulation linked to altered PI3Kẟ signaling in lymphocytes PIDs to include ALPS-FAS, CTLA4 haploinsufficiency, NFKB1...